Back to 
BALYASNY ASSET MANAGEMENT L.P.
BALYASNY ASSET MANAGEMENT L.P.
LGND
Showing 0 of 2 quarters
Position history for BALYASNY ASSET MANAGEMENT L.P.'s holdings in LIGAND PHARMACEUTICALS INC
No. Balyasny Asset Management exited its LGND (Ligand Pharmaceuticals) position in Q2 2019. Its Q1 2019 13F listed 5,147 shares worth $647,000. Balyasny Asset Management first reported LGND in Q1 2019 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.